Table 2 Descriptive characteristics of participants
From: Metabolic syndrome and its predictors in an urban population in Kenya: A cross sectional study
Male (n = 255) | Female (n = 273) | Total (n = 528) | Male vs Female | ||||
|---|---|---|---|---|---|---|---|
Median (IQR) | Min-Max | Median (IQR) | Min-Max | Median (IQR) | Min-Max | p-value | |
Age (years) | 38 (19) | 20–65 | 39 (21) | 18–64 | 39 (20) | 18–65 | 0.986* |
BMI (kg/m2) | 24.87 (5.66) | 16.29–34.94 | 26.10 (6.25) | 17.10–38.05 | 25.46 (5.96) | 16.29–38.05 | 0.000† |
LAP | 29.52 (40.95) | 0.00–388.87 | 23.97 (29.69) | 3.30–205.54 | 26.94 (35.96) | 0.00–388.87 | 0.055* |
VAI | 1.51 (1.45) | 0.26–21.66 | 1.35 (1.13) | 0.42–20.42 | 1.43 (1.22) | 0.26–21.66 | 0.163* |
WC (cm) | 90 (15) | 65–124 | 86 (16) | 64–115 | 89 (17) | 64–124 | 0.000† |
SBP (mmHg) | 127 (18) | 94–167 | 118 (20) | 77–194 | 123.5 (20) | 77–194 | 0.000† |
DBP (mmHg) | 81 (12) | 56–101 | 79 (14) | 57–112 | 80 (14) | 56–112 | 0.003† |
FPG (mmol/L) | 4.9 (0.8) | 3.0–15.6 | 4.8 (0.7) | 3.3–19.5 | 4.9 (0.8) | 3.0–19.5 | 0.022† |
TC (mmol/L) | 4.7 (1.2) | 2.3–8.2 | 4.6 (1.2) | 2.6–7.7 | 4.6 (1.1) | 2.3–8.2 | 0.732* |
HDL-C (mmol/L) | 1.1 (0.3) | 0.5–2.0 | 1.2 (0.3) | 0.3–2.4 | 1.1 (0.3) | 0.3–2.4 | 0.000† |
cLDL-C (mmol/L) | 2.9 (1.1) | 1.0–5.8 | 2.9 (1.0) | 1.1–5.4 | 2.9 (1.0) | 1.0–5.8 | 0.650* |
mLDL-C (mmol/L) | 2.9 (1.1) | 0.9–5.8 | 2.8 (1.0) | 1.3–5.2 | 2.8 (1.1) | 0.9–5.8 | 0.141* |
TG (mmol/L) | 1.2 (0.90) | 0.32–10.51 | 0.9 (0.61) | 0.33–4.78 | 1.05 (0.75) | 0.32–10.51 | 0.000† |
UA (mmol/L) | 0.35 (0.10) | 0.18–0.64 | 0.27 (0.08) | 0.13–0.47 | 0.31 (0.11) | 0.13–0.64 | 0.000† |
ALP (U/L) | 86 (35) | 34–179 | 84 (38) | 31–191 | 85 (37) | 31–191 | 0.497* |
ALT (U/L) | 21 (14) | 8–96 | 14 (9) | 6–123 | 18 (11) | 6–123 | 0.000† |
AST (U/L | 25 (8) | 14–73 | 21 (6) | 11–102 | 23 (7) | 11–102 | 0.000† |
GGT (U/L) | 31 (24) | 9–701 | 21 (12) | 7–211 | 25 (19) | 7–701 | 0.000† |
hsCRP (mg/L) | 0.99 (2.05) | 0.20–36.25 | 1.65 (3.19) | 0.20–60.75 | 1.31 (2.63) | 0.20–60.80 | 0.000† |